| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |